Rockwell Medical (RMTI) 10-Q2024 Q3 Quarterly report

Filed: 12 Nov 24, 7:10am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: binding, digit, diversify, East, EPS, footnote, gain, higher, Middle, notification, notified, prospectively, retrospectively, split, stipulated, Subtopic

Removed: calculating, commitment, issuable, month, nominal, registration, resale, thereof, vested

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated RMTI transcripts

RMTI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Rockwell Medical, Inc. (the “Company”) on Form 10‑Q for the quarter ending June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Periodic Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:

1.the Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: November 12, 2024			/s/ Mark Strobeck
			Mark Strobeck (Principal Executive Officer and Principal Financial Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.